Membrane allograft for diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a special membrane made from donated birth tissue (perinatal membrane) placed on a diabetic foot ulcer to help it heal faster. It's for people with diabetes whose foot ulcer hasn't healed after standard care for 4 weeks to a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have type 1 or type 2 diabetes.
- Your foot ulcer is on the lower part of your foot (below the ankle) and is between 1 and 20 square centimeters after cleaning.
- The ulcer has been present for at least 4 weeks but no more than 52 weeks.
- You have good blood flow to your foot (a doctor will check this).
- The ulcer is not infected, you do not have bone infection, and you are not on certain medications (like high-dose steroids or chemotherapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a wound covering made from donated amniotic tissue (dehydrated human amnion membrane) placed on a diabetic foot ulcer that isn't healing. It aims to see if adding this membrane to standard wound care helps the ulcer close faster.
This study tests whether a special placental tissue graft placed on a diabetic foot ulcer helps it heal faster than standard wound care alone. It is for people with a diabetic foot ulcer that has not healed after 4 weeks of usual care.
This study tests a special patch made from placental tissue that is placed on a diabetic foot ulcer to help it heal. It aims to see if this patch works better than standard care alone. If you have a chronic foot ulcer from diabetes, this trial might offer a new treatment option.
This trial tests if a placental membrane product, when added to standard wound care, helps heal diabetic foot ulcers and venous leg ulcers faster than standard care alone.
This study tests whether a special wound dressing made from human placental membrane can help heal diabetic foot ulcers or venous leg ulcers that did not close with standard care. It is for people who were in the BIOCAMP trial and whose ulcer remained open after 12 weeks of standard treatment.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.